Search Results - "Wailoo, Allan"
-
1
Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report
Published in Value in health (2017)“…Abstract Economic evaluation conducted in terms of cost per quality-adjusted life-year (QALY) provides information that decision makers find useful in many…”
Get full text
Journal Article -
2
Haemorrhoidal artery ligation versus rubber band ligation for the management of symptomatic second-degree and third-degree haemorrhoids (HubBLe): a multicentre, open-label, randomised controlled trial
Published in The Lancet (British edition) (23-07-2016)“…Summary Background Optimum surgical intervention for low-grade haemorrhoids is unknown. Haemorrhoidal artery ligation (HAL) has been proposed as an…”
Get full text
Journal Article -
3
Tails from the Peak District: Adjusted Limited Dependent Variable Mixture Models of EQ-5D Questionnaire Health State Utility Values
Published in Value in health (01-05-2012)“…Abstract Objectives Health utility data generated by using the EuroQol five-dimensional (EQ-5D) questionnaire are right bounded at 1 with a substantial gap to…”
Get full text
Journal Article -
4
Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer
Published in BMC cancer (18-11-2021)“…The types of outcomes measured collected in clinical studies and those required for cost-effectiveness analysis often differ. Decision makers routinely use…”
Get full text
Journal Article -
5
Use of MRI in the diagnosis of fetal brain abnormalities in utero (MERIDIAN): a multicentre, prospective cohort study
Published in The Lancet (British edition) (04-02-2017)“…Summary Background In-utero MRI (iuMRI) has shown promise as an adjunct to ultrasound but the comparative diagnostic performance has been poorly defined. We…”
Get full text
Journal Article -
6
Valuing health at the end of life: a stated preference discrete choice experiment
Published in Social science & medicine (1982) (01-01-2015)“…A source of debate in the field of health care priority setting is whether health gains should be weighted differently for different groups of patients. The…”
Get full text
Journal Article -
7
The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment
Published in PharmacoEconomics (01-12-2017)“…Background Recent changes to the regulatory landscape of pharmaceuticals may sometimes require reimbursement authorities to issue guidance on technologies that…”
Get full text
Journal Article -
8
Convergent validity of EQ-5D with core outcomes in dementia: a systematic review
Published in Health and quality of life outcomes (19-11-2022)“…Abstract Objectives To explore through a systematic review, the convergent validity of EQ-5D (EQ-5D-3L and EQ-5D-5L (total score and dimensions)) with core…”
Get full text
Journal Article -
9
Valuing health at the end of life: A review of stated preference studies in the social sciences literature
Published in Social science & medicine (1982) (01-05-2018)“…A source of debate in the health care priority setting literature is whether to weight health gains to account for equity considerations, such as concern for…”
Get full text
Journal Article -
10
The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study
Published in Health technology assessment (Winchester, England) (01-11-2016)“…Giant cell arteritis (GCA) is a relatively common form of primary systemic vasculitis, which, if left untreated, can lead to permanent sight loss. We compared…”
Get full text
Journal Article -
11
Assessing the psychometric performance of EQ-5D-5L in dementia: a systematic review
Published in Health and quality of life outcomes (28-09-2022)“…Abstract Background EQ-5D is widely used for valuing changes in quality of life for economic evaluation of interventions for people with dementia. There are…”
Get full text
Journal Article -
12
Does EQ-5D Tell the Whole Story? Statistical Methods for Comparing the Thematic Coverage of Clinical and Generic Outcome Measures, With Application to Breast Cancer
Published in Value in health (01-09-2023)“…This study aimed to develop the following: (1) methods for assessing claims in any specific application that a generic outcome measure, such as EQ-5D is…”
Get full text
Journal Article -
13
Correction to: Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer
Published in BMC cancer (27-01-2022)Get full text
Journal Article -
14
Using Health State Utility Values in Models Exploring the Cost-Effectiveness of Health Technologies
Published in Value in health (01-09-2012)“…Abstract Background To improve comparability of economic data used in decision making, some agencies recommend that a particular instrument should be used to…”
Get full text
Journal Article -
15
Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping
Published in Value in health (01-12-2018)“…Preference-based measures of health, such as the three-level EuroQol five-dimensional questionnaire (EQ-5D-3L), are required to calculate quality-adjusted…”
Get full text
Journal Article -
16
Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation study
Published in BMC medical research methodology (11-01-2011)“…We investigate methods used to analyse the results of clinical trials with survival outcomes in which some patients switch from their allocated treatment to…”
Get full text
Journal Article -
17
Development of Methods for the Mapping of Utilities Using Mixture Models: Mapping the AQLQ-S to the EQ-5D-5L and the HUI3 in Patients with Asthma
Published in Value in health (01-06-2018)“…Studies have shown that methods based on mixture models work well when mapping clinical to preference-based methods. To develop these methods in different ways…”
Get full text
Journal Article -
18
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation
Published in Health technology assessment (Winchester, England) (01-04-2016)“…Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with increasing disability, reduced quality of life and substantial costs (as a result…”
Get full text
Journal Article -
19
Health Assessment Questionnaire disability progression in early rheumatoid arthritis: Systematic review and analysis of two inception cohorts
Published in Seminars in arthritis and rheumatism (01-10-2014)“…Abstract Objective The Health Assessment Questionnaire is widely used for patients with inflammatory polyarthritis (IP) and its subset, rheumatoid arthritis…”
Get full text
Journal Article -
20
Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods
Published in Health technology assessment (Winchester, England) (01-06-2020)“…Cost-effectiveness analysis using quality-adjusted life-years as the measure of health benefit is commonly used to aid decision-makers. Clinical studies often…”
Get full text
Journal Article